SEC Nets Win In Suit Over Ex-CEO's Alleged Revenue Scheme
A Washington, D.C., federal judge on Thursday largely sided with the U.S. Securities and Exchange Commission in its civil enforcement case against the former CEO of RTI Surgical Holdings, finding he misled inv... (more story)
Judge Sets Feb. Trial In States' Generics Price-Fixing Suit
A Connecticut federal judge has set a February trial date on claims from dozens of state attorneys general that generic-drug makers conspired to artificially inflate the prices of generic topical drugs.
Tarsus Bets Up To $800M On Alkeus In Retina Therapy Push
Tarsus Pharmaceuticals Inc. said Thursday it has agreed to acquire privately held Alkeus Pharmaceuticals Inc. for up to approximately $800 million, expanding the Irvine, California-based eye care company's pip... (more story)
Chancery Sets Hybrid Interest Formula In Alexion Merger Fight
The Delaware Chancery Court has adopted a hybrid method for calculating prejudgment interest in the long-running merger dispute between Shareholder Representative Services LLC and Alexion Pharmaceuticals Inc.,... (more story)
Fenwick-Led Attovia Therapeutics Prices Upsized $289M IPO
Early-stage biotechnology company Attovia Therapeutics hit the public markets on Wednesday after it raised $289 million in its upsized initial public offering.
Kirkland, Jones Day Guide P&G's $3.8B Buy Of Thorne
Procter & Gamble is acquiring supplements company Thorne from L Catterton for $3.8 billion in cash, with Kirkland & Ellis LLP and Jones Day serving as legal advisers in the transaction, the companies announced Tuesday.